Royal Bank of Canada’s Immunic IMUX Stock Holding History

Royal Bank of Canada’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3K	Buy	301 +297	+7,425%	+$2.66K	﹤0.01%	6592
2025 Q4	$0	Sell	4 -5,436	-100%	-$39.8K	﹤0.01%	7371
2025 Q3	$48K	Buy	5,440 +3,270	+151%	+$28.8K	﹤0.01%	5837
2025 Q2	$15K	Buy	2,170 +2,165	+43,300%	+$19.9K	﹤0.01%	6356
2025 Q1	$0	Hold	5	–	–	﹤0.01%	7017
2024 Q4	$0	Hold	5	–	–	﹤0.01%	7060
2024 Q3	$0	Sell	5 -65	-93%	-$925	﹤0.01%	7112
2024 Q2	$1K	Buy	70 +65	+1,300%	+$807	﹤0.01%	6829
2024 Q1	$0	Sell	5 -14	-74%	-$182	﹤0.01%	7265
2023 Q4	$0	Buy	19 +14	+280%	+$172	﹤0.01%	7327
2023 Q3	$0	Hold	5	–	–	﹤0.01%	7309
2023 Q2	$0	Hold	5	–	–	﹤0.01%	7428
2023 Q1	$0	Sell	5 -10	-67%	-$186	﹤0.01%	7253
2022 Q4	$0	Sell	15 -100	-87%	-$2.73K	﹤0.01%	7448
2022 Q3	$3K	Hold	115	–	–	﹤0.01%	6895
2022 Q2	$4K	Sell	115 -114	-50%	-$7.3K	﹤0.01%	6724
2022 Q1	$26K	Sell	229 -280	-55%	-$32.4K	﹤0.01%	6466
2021 Q4	$49K	Sell	509 -826	-62%	-$74.4K	﹤0.01%	6383
2021 Q3	$118K	Buy	1,335 +124	+10%	+$12.2K	﹤0.01%	5591
2021 Q2	$149K	Buy	1,211 +165	+16%	+$22.8K	﹤0.01%	5314
2021 Q1	$167K	Buy	1,046 +13	+1%	+$2.21K	﹤0.01%	5089
2020 Q4	$158K	Buy	1,033 +917	+791%	+$165K	﹤0.01%	5028
2020 Q3	$22K	Buy	116 +101	+673%	+$16.5K	﹤0.01%	5659
2020 Q2	$2K	Buy	15 +8	+114%	+$814	﹤0.01%	6282
2020 Q1	$0	Buy	7 +2	+40%	+$161	﹤0.01%	6828
2019 Q4	$0	Sell	5 -1	-17%	-$83	﹤0.01%	6947
2019 Q3	$0	Buy	6 +1	+20%	+$134	﹤0.01%	6888
2019 Q2	$1K	Hold	5	–	–	﹤0.01%	6705
2019 Q1	$0	Hold	5	–	–	﹤0.01%	6937
2018 Q4	$0	Sell	5 -2	-29%	-$234	﹤0.01%	6914
2018 Q3	$0	Buy	+7	New	+$18.3K	﹤0.01%	6814
2018 Q2	–	Hold	0	–	–	–	6359
2018 Q1	–	Hold	0	–	–	–	6548
2017 Q4	–	Hold	0	–	–	–	6694
2017 Q3	–	Sell	-1	Closed	-$1.3K	–	6818
2017 Q2	$1K	Sell	1 -1	-50%	-$1.33K	﹤0.01%	6401
2017 Q1	$4K	Sell	2 -2	-50%	-$3.66K	﹤0.01%	6278
2016 Q4	$7K	Buy	+4	New	+$8.76K	﹤0.01%	6201
2016 Q1	–	Hold	0	–	–	–	6496
2015 Q4	–	Sell	-2	Closed	-$6.53K	–	6728
2015 Q3	$3K	Hold	2	–	–	﹤0.01%	6303
2015 Q2	$20K	Buy	+2	New	+$19.1K	﹤0.01%	5704
2015 Q1	–	Hold	0	–	-$3K	–	6263
2014 Q4	–	Hold	0	–	–	–	5909
2014 Q3	–	Hold	0	–	–	–	5795

Other funds holding IMUX

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Royal Bank of Canada's IMUX Position: Q1 2026 in Review

Royal Bank of Canada increased its Immunic (IMUX) stake by 7,425% in Q1 2026, buying an estimated $2.66K and bringing the position to 301 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #6592.

Royal Bank of Canada first reported a position in IMUX in Q2 2015 and has held it in 36 quarters since. The position peaked at $167K in Q1 2021. 75 funds tracked by Wall St. Rank hold IMUX as of Q1 2026.

Royal Bank of Canada held 301 shares of Immunic worth $3K as of Q1 2026.
Royal Bank of Canada bought 297 Immunic shares in Q1 2026, an estimated $2.66K.
Immunic made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6592 holding.
Royal Bank of Canada first reported a position in Immunic in Q2 2015 and has held it in 36 quarters since.
Royal Bank of Canada's Immunic position peaked at $167K in Q1 2021.
75 funds tracked by Wall St. Rank held Immunic as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.